In vitro studies favor a possible neuroprotective role for melanocortins, as they suppressed NF-kB activation in TNF-α-activated Schwann cells or lipopolysaccharide-activated glioma cells [29,118,119,120]. Here, NFKB1 is linked to central nervous system cancer.